Norman Maitland: Multicellular models of human prostate: the influence of the microenvironment
Richard Morgan: Targeting HOX transcription factors in prostate cancer

Declan McKenna: The significance of a hypoxic tumour microenvironment in prostate cancer

Jason Webber: Modulation of stroma by prostate cancer exosomes

Maria Sadiq: Probing the expression &function of aldehyde dehydrogenases in prostate cancer using ALDH-affinic compounds & siRNAs

Rhiannon French: FLIPi: Evaluating a novel therapeutic strategy to target advanced prostate cancer

Rachel Howard-Jones: The mandible slice model to emulate dynamic cellular responses of the bone niche

​

Vincent Yeung: Rab GTPases control secretion of stroma-activating exosome sub-populations

Fiona Frame: Tumour heterogeneity and therapy resistance - implications for future treatments of prostate cancer

Agnese Pippione: Targeting CRPC with innovative AKR1C3 inhibitors obtained through scaffold hopping approach

Rob Falconer: Exploiting the prostate tumour microenvironment for targeted drug delivery

Marco Lolli: The role of AKR1C3 in CRPC: an opportunity to design effective drugs?

Hardev Pandha: Oncolytic immunotherapy for prostate cancer
Malcolm Mason: Major trials in prostate cancer; lessons from the clinic for the lab

​